Deconstructing the transdiagnostic nature of language symptoms in frontotemporal dementias

23 November 2022, Version 1
This content is an early or alternative research output and has not been peer-reviewed by Cambridge University Press at the time of posting.

Abstract

Primary progressive aphasia (PPA) is a group of neurodegenerative disorders featuring primary-language impairments and typically classified into three-variants: semantic, non-fluent and logopenic. Yet their language profiles significantly overlap. Language deficits can also occur in other frontotemporal dementias (FTD) like progressive supranuclear palsy and corticobasal syndrome, suggesting that language symptoms are transdiagnostic. Though brain atrophy determines language difficulties, similar atrophy profiles often are related to different language deficits, and different atrophies can cause similar impairments (e.g., logopenic/non-fluent PPA). We apply a transdiagnotic approach to link the language variantions across FTD-PPA spectrum to their underlying neuroanatomical factors. Principal component analysis identified three language dimensions (motor-speech/phonology, semantics and syntax) and thirteen atrophic dimensions, including temporal, frontal, parietal regions. While anterior temporal lobe atrophy predicts semantic impairments, frontoparietal atrophies predict motor-speech/phonology, and syntax. Atrophy and language variations across FTD-PPA syndromes are deconstructed on a brain-behaviour continuum, with only semantic variants being clearly separate.

Keywords

pca
frontotemporal lobar degeneration
language impariments
frontotemporal dementia
primary progressive aphasia

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting and Discussion Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.